Investing.com -- BTIG attended the Boston Digital Health Innovation Summit 2026 at the Seaport Hotel in Boston, where investors, venture capitalists, and management teams from companies including Noom, Cityblock, Lark, and Devoted Health gathered to discuss industry developments.

The conference highlighted trends in managing Medicaid members with quality care in cost-effective settings, Medicare Advantage services for aging populations, and ongoing efforts in obesity health and weight loss. Discussions also covered artificial intelligence applications and the current healthcare technology capital raising environment.

Capital markets have reset, with investors now requiring healthcare companies to demonstrate public-company discipline before any initial public offering, according to consensus across panels. Trust, governance, predictable execution, repeatable revenue, and a clear path to profitability have become prerequisites. Recent underperformance of Medicare Advantage and risk-bearing public companies reinforced that growth without earnings is no longer acceptable. Durability, cash flow, and proven management teams are now central to valuation and capital access.

Artificial intelligence has evolved from a standalone product to an operating foundation that must be embedded into workflows, cost structures, and care delivery models. Leaders emphasized tying AI directly to operational outcomes, including reducing administrative burden, improving coordination, and enhancing patient experience. Human-in-the-loop models remain essential in complex care environments.

Investor and operator dialogue showed renewed focus on technology-enabled healthcare services, particularly value-based, outcomes-oriented care models. Speakers emphasized that sustainable defensibility comes from services businesses that deliver demonstrable outcomes, trust, and longitudinal engagement. Technology-enabled services leveraging automation and AI offer improved economics compared to traditional services models.

BTIG identified stocks expected to benefit from these trends, including Astrana (NASDAQ: ASTH), BrightSpring (NASDAQ: BTSG), Medline (NASDAQ: MDLN), LifeStance (NASDAQ: LFST), LifeMD (NASDAQ: LFMD), The Oncology Institute (NASDAQ: TOI), Veeva (NYSE: VEEV), and Doximity (NYSE: DOCS).